Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enterprise Therapeutics Ltd.

Latest From Enterprise Therapeutics Ltd.

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Private Company Edition: Investments by CIRM, the GHIT fund and the European Investment Bank back early-stage science and treatments for neglected diseases. Also, Versant Ventures raises $700m in two funds. In VC deals, Akero raised $70m, Impel NeuroPharma brought in $67.5m.

Financing StartUps and SMEs

Pre-Brexit: UK Biotechs Still Dominate European Fundraising

Using data provided by Informa Pharma Intelligence, the UK BioIndustry Association reports that UK biotechs continue to take the lion's share of European fundraising.

 

Europe Analysis

Record Breaking First Half For Start-Ups Raising Cash In Europe

The first half of 2018 appeared promising for the European biopharma sector, with multiple large investment funds promising cash to young, innovative companies in the region – a turnaround after years of life science firms suffering from a funding drought across Europe.

Growth Financing

Enterprise Therapeutics Raises £29M To Advance Respiratory Assets

UK biopharma Enterprise Therapeutics raises £29M in a series B round co-led by Versant Ventures and Novartis Venture Fund to advance pipeline of novel respiratory disease treatments into clinical development.

Commercial Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Enterprise Therapeutics Ltd.
  • Senior Management
  • John Ford, PhD, CEO
    Phil Boyd, PhD, CFO
    Martin Gosling, CSO
  • Contact Info
  • Enterprise Therapeutics Ltd.
    Phone: (0)1273 234667
    Sussex Innovation Ctr.
    Science Pk. Sq.
    Brighton, BN1 9SB
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register